bioCSL has commenced distribution of Immucor’s Capture technology platform and reagents in Australia and New Zealand. Capture is antibody detection technology used in the crossmatching of blood used for transfusion.
The technology is said to work differently from the techniques commonly used in Australia, delivering high levels of specificity and potentially reducing both the need for additional testing and delays for patients awaiting a blood transfusion. The product has a high degree of sensitivity for detection of clinically significant antibodies, providing confidence and accuracy in pre‐transfusion and prenatal screening.
Phone: 1300 369 559
ProImmune ProVE SL Self-Loading MHC Class I Monomers
The novel reagents for antigen-specific CD8+ T cell detection are designed to offer...
HAWK Biosystems Quantifying Functions in Proteins (QF-Pro) reagent kits
HAWK Biosystems' Quantifying Functions in Proteins (QF-Pro) reagent kits contain the tailored...
Amsbio validated cytokines for organoid culture
Amsbio has launched over a range of over 30 independently developed and manufactured organoid...
